DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554,579 | -2.2% | 61,895 | +22.8% | 0.00% | – |
| Q2 2023 | $566,854 | +1007.0% | 50,387 | +1033.6% | 0.00% | – |
| Q1 2023 | $51,206 | -56.6% | 4,445 | -56.3% | 0.00% | – |
| Q4 2022 | $117,859 | -92.7% | 10,169 | -92.0% | 0.00% | -100.0% |
| Q3 2022 | $1,608,000 | -41.9% | 126,578 | -68.6% | 0.00% | -50.0% |
| Q2 2022 | $2,766,000 | +3741.7% | 402,656 | +5322.2% | 0.00% | – |
| Q1 2022 | $72,000 | -56.4% | 7,426 | -46.6% | 0.00% | – |
| Q4 2021 | $165,000 | +166.1% | 13,919 | +267.2% | 0.00% | – |
| Q3 2021 | $62,000 | +55.0% | 3,791 | +101.9% | 0.00% | – |
| Q2 2021 | $40,000 | +135.3% | 1,878 | +75.8% | 0.00% | – |
| Q1 2021 | $17,000 | -69.6% | 1,068 | -59.8% | 0.00% | – |
| Q4 2020 | $56,000 | – | 2,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $103,977,000 | 14.71% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,161,000 | 12.76% |
| Octagon Capital Advisors LP | 481,538 | $10,112,000 | 3.50% |
| Logos Global Management LP | 1,604,392 | $33,692,000 | 2.89% |
| RA Capital Management | 2,805,045 | $58,906,000 | 0.82% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 12,048 | $253,000 | 0.40% |
| HighVista Strategies LLC | 23,760 | $499,000 | 0.32% |
| Vivo Capital, LLC | 315,000 | $6,615,000 | 0.30% |
| Woodline Partners LP | 490,986 | $10,311,000 | 0.27% |
| EcoR1 Capital, LLC | 215,000 | $4,515,000 | 0.24% |